Probiotic Lactobacillus and Bifidobacterial Lectins Against Candida albicans and Staphylococcus aureus Clinical Strains: New Class of the Pathogen Biofilm Destructors

Probiotics and Antimicrobial Proteins
M LakhtinV Pospelova

Abstract

Preparations of probiotic bifidobacterial and lactobacillus lectins possessed system affinity to mannan and mucin-type polymers. It was shown that these lectins possess fungistatic and fungicidal activities against nystatin-resistant Candida albicans clinical strains. Lectins revealed destructive properties with respect to C. albicans and Staphylococcus aureus biofilms, depending on clinical strain origin and lectin preparation type. Synergistic antipathogen activities between lectins and between lectins and nystatin were observed. In the presence of lectins, pathogen biofilm degradation occurred in sequential steps, including biofilm refinement, appearance of edge cavities, segmentation, detachment of fragments and their lysis. Fungal response to lectins was more complex compared to that of staphylococci. Cold stress improved pictures of lectin antipathogen action. The data indicate that probiotic bacterial lectins are members of a new class of antimicrobials-destructors of pathogen biofilms.

References

Sep 1, 1993·FEMS Microbiology Reviews·T R Klaenhammer
Jun 12, 2004·The Journal of Dairy Research·Graciela Liliana GarroteGraciela Liliana De Antoni
Oct 27, 2004·Infection and Immunity·James Masuoka, Kevin C Hazen
Apr 25, 2006·Research in Microbiology·Hideaki UchidaTadao Saito
Aug 23, 2006·Antimicrobial Agents and Chemotherapy·Michael D LaFleurKim Lewis
May 16, 2007·Antimicrobial Agents and Chemotherapy·Palani PerumalW LaJean Chaffin
Jul 16, 2008·Antimicrobial Agents and Chemotherapy·C J SeneviratneL P Samaranayake
Dec 5, 2008·Microbiology and Molecular Biology Reviews : MMBR·Sarah LebeerSigrid C J De Keersmaecker
Apr 7, 2009·Applied and Environmental Microbiology·Catrin Stichternoth, Joachim F Ernst
Jul 5, 2011·Anaerobe·Vladimir LakhtinVladimir Alyoshkin

❮ Previous
Next ❯

Citations

Jul 2, 2014·BioMed Research International·Mayron Alves VasconcelosMaria Olivia Pereira
Jul 5, 2011·Anaerobe·Vladimir LakhtinVladimir Alyoshkin
Jul 19, 2012·Bulletin of Experimental Biology and Medicine·E Yu Zlatnik, L V Peredreyeva
Apr 1, 2020·Klinicheskaia laboratornaia diagnostika·M V LakhtinS S Afanasiev
Oct 1, 2020·Journal of Fungi·Lohith KunyeitReeta P Rao
Feb 11, 2015·Probiotics and Antimicrobial Proteins·K Poornachandra RaoM Y Sreenivasa
Mar 4, 2021·Probiotics and Antimicrobial Proteins·Paulina CzechowiczWojciech Kamysz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.